We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Brixmor Property Group
BRX
$9.75B
| $4.06M | 0.01% |
195,317
-3,708
| -2% | -$82.2K |
|
627
Jazz Pharmaceuticals
JAZZ
$16.1B
| $4.06M | 0.01% |
31,329
+7,429
| +31% | +$990K |
|
628
NewAmsterdam Pharma
NAMS
$3.27B
| $4.05M | 0.01% |
437,733
-4,223
| -1% | -$45.7K |
|
629
Applied Industrial Technologies
AIT
$12.4B
| $4.04M | 0.01% |
26,133
+8,018
| +44% | +$1.2M |
|
|
CHX
630
DELISTED
ChampionX
CHX
| $4.03M | 0.01% |
113,273
-6,937
| -6% | -$247K |
|
631
Stanley Black & Decker
SWK
$14.3B
| $4.03M | 0.01% |
48,160
| – | – |
|
632
Newmont
NEM
$94.6B
| $3.99M | 0.01% |
107,960
-210,835
| -66% | -$8.57M |
|
633
Dynatrace
DT
$12.8B
| $3.96M | 0.01% |
84,770
+12,610
| +17% | +$619K |
|
634
Charles River Laboratories
CRL
$11.5B
| $3.94M | 0.01% |
20,112
-188
| -0.9% | -$38.6K |
|
635
CubeSmart
CUBE
$9.71B
| $3.93M | 0.01% |
103,101
+13,621
| +15% | +$575K |
|
636
Zentalis Pharmaceuticals
ZNTL
$325M
| $3.91M | 0.01% |
194,933
| – | – |
|
637
Burlington
BURL
$23.5B
| $3.87M | 0.01% |
28,590
-425
| -1% | -$68.2K |
|
638
Vail Resorts
MTN
$5.65B
| $3.86M | 0.01% |
17,385
+560
| +3% | +$133K |
|
639
Northern Trust
NTRS
$22.1B
| $3.85M | 0.01% |
55,426
-872
| -2% | -$65.9K |
|
640
CarMax
KMX
$8.63B
| $3.84M | 0.01% |
54,291
| – | – |
|
641
Tradeweb Markets
TW
$22.6B
| $3.84M | 0.01% |
47,875
+1,920
| +4% | +$153K |
|
|
P
642
Everpure Inc
P
$23.7B
| $3.84M | 0.01% |
107,785
-16,650
| -13% | -$617K |
|
643
Outset Medical
OM
$86.4M
| $3.84M | 0.01% |
23,522
+5,628
| +31% | +$1.33M |
|
644
Lantheus
LNTH
$6.44B
| $3.82M | 0.01% |
54,992
-4,668
| -8% | -$341K |
|
645
Unum
UNM
$13.2B
| $3.82M | 0.01% |
77,593
-32,132
| -29% | -$1.57M |
|
646
Hilton Worldwide
HLT
$72.3B
| $3.79M | 0.01% |
25,264
-35,082
| -58% | -$5.3M |
|
647
Viatris
VTRS
$20.8B
| $3.79M | 0.01% |
384,501
| – | – |
|
648
Landstar System
LSTR
$6.2B
| $3.79M | 0.01% |
21,396
+1,090
| +5% | +$209K |
|
649
Lincoln Electric
LECO
$14.2B
| $3.78M | 0.01% |
20,782
+6,047
| +41% | +$1.16M |
|
650
Health Catalyst
HCAT
$159M
| $3.76M | 0.01% |
371,556
-324,035
| -47% | -$3.87M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.